About the Authors

Tao Xie

tao.xie@pfizer.com (TX); hodgson.graeme@gmail.com (JGH)

Affiliation Oncology Research, Pfizer Worldwide Research and Development, San Diego, California, United States of America

Giovanni d’ Ario

Affiliation Swiss Institute of Bioinformatics, Lausanne, Switzerland

John R. Lamb

Affiliation Oncology Research, Pfizer Worldwide Research and Development, San Diego, California, United States of America

Eric Martin

Affiliation Oncology Research, Pfizer Worldwide Research and Development, San Diego, California, United States of America

Kai Wang

Affiliation Oncology Research, Pfizer Worldwide Research and Development, San Diego, California, United States of America

Sabine Tejpar

Affiliation University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium

Mauro Delorenzi

Affiliations Swiss Institute of Bioinformatics, Lausanne, Switzerland, Lausanne University Medical Center, Lausanne, Switzerland

Fred T. Bosman

Affiliation Lausanne University Medical Center, Lausanne, Switzerland

Arnaud D. Roth

Affiliation Geneva University Hospital, Geneva, Switzerland

Pu Yan

Affiliation Lausanne University Medical Center, Lausanne, Switzerland

Stephanie Bougel

Affiliation Lausanne University Medical Center, Lausanne, Switzerland

Antonio Fabio Di Narzo

Affiliation Swiss Institute of Bioinformatics, Lausanne, Switzerland

Vlad Popovici

Affiliation Swiss Institute of Bioinformatics, Lausanne, Switzerland

Eva Budinská

Affiliation Swiss Institute of Bioinformatics, Lausanne, Switzerland

Mao Mao

Affiliation Oncology Research, Pfizer Worldwide Research and Development, San Diego, California, United States of America

Scott L. Weinrich

Affiliation Oncology Research, Pfizer Worldwide Research and Development, San Diego, California, United States of America

Paul A. Rejto

Affiliation Oncology Research, Pfizer Worldwide Research and Development, San Diego, California, United States of America

J. Graeme Hodgson

tao.xie@pfizer.com (TX); hodgson.graeme@gmail.com (JGH)

Affiliation Oncology Research, Pfizer Worldwide Research and Development, San Diego, California, United States of America

Competing Interests

TX, JL, KW, MM, SW, PR and JGH are or were employed by Pfizer Inc. However, this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The authors have declared that no other competing interests exist.

Author Contributions

Conceived and designed the experiments: TX ST MD JGH. Analyzed the data: TX GA EM KW AFDN VP EB JGH. Contributed reagents/materials/analysis tools: ST FTB ADR PY SB SLW. Wrote the paper: TX GA JRL ST MD VP MM PAR JGH.